|
1
|
Ali J, Sabiha B, Jan HU, Haider SA, Khan AA and Ali SS: Genetic etiology of oral cancer. Oral Oncol. 70:23–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA CancerJ Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, Luttmann S, Kraywinkel K and Brenner H; GEKID Cancer Survival Working Group, : Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral Oncol. 76:8–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE and Grandis JR: Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 6:922020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aires FT, Lin CS, Matos LL, Kulcsar MAV and Cernea CR: Risk factors for distant metastasis in patients with oral cavity squamous cell carcinoma undergoing surgical treatment. ORL J Otorhinolaryngol Relat Spec. 79:347–355. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chi AC, Day TA and Neville BW: Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y and Weinberg RA: Epithelial-to-mesenchymal transition in cancer: Complexity and opportunities. Front Med. 12:361–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gloushankova NA, Zhitnyak IY and Rubtsova SN: Role of epithelial-mesenchymal transition in tumor progression. Biochemistry (Mosc). 83:1469–1476. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, Van Keymeulen A, Brown D, Moers V, Lemaire S, et al: Identification of the tumour transition states occurring during EMT. Nature. 556:463–468. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nieto MA, Huang RY, Jackson RA and Thiery JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng XL, Ho SC, Mo XF, Lin FY, Zhang NQ, Luo H, Zhang X and Zhang CX: Association between flavonoids, flavonoid subclasses intake and breast cancer risk: A case-control study in China. Eur J Cancer Prev. 29:493–500. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Surichan S, Arroo RR, Ruparelia K, Tsatsakis AM and Androutsopoulos VP: Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes. Food Chem Toxicol. 113:228–235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen M, Li H, Zheng S, Shen J, Chen Y, Li Y, Yuan M, Wu J and Sun Q: Nobiletin targets SREBP1/ACLY to induce autophagy-dependent cell death of gastric cancer cells through PI3K/Akt/mTOR signaling pathway. Phytomedicine. 128:1553602024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uesato S, Yamashita H, Maeda R, Hirata Y, Yamamoto M, Matsue S, Nagaoka Y, Shibano M, Taniguchi M, Baba K and Ju-ichi M: Synergistic antitumor effect of a combination of paclitaxel and carboplatin with nobiletin from Citrus depressa on non-small-cell lung cancer cell lines. Planta Med. 80:452–457. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma X, Jin S, Zhang Y, Wan L, Zhao Y and Zhou L: Inhibitory effects of nobiletin on hepatocellular carcinoma in vitro and in vivo. Phytother Res. 28:560–567. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng HL, Hsieh MJ, Yang JS, Lin CW, Lue KH, Lu KH and Yang SF: Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression. Oncotarget. 7:35208–35223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rosas-Martínez M, González Rosales JA and Gutiérrez-Venegas G: Nobiletin regulates invasion, migration and metastasis in hypopharyngeal squamous cell carcinoma. Cell Mol Biol (Noisy-le-grand). 69:1–6. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiou YS, Zheng YN, Tsai ML, Lai CS, Ho CT and Pan MH: 5-Demethylnobiletin more potently inhibits colon cancer cell growth than nobiletin in vitro and in vivo. J Food Bioact. 2:91–97. 2018. View Article : Google Scholar
|
|
19
|
Zheng J, Bi J, Johnson D, Sun Y, Song M, Qiu P, Dong P, Decker E and Xiao H: Analysis of 10 metabolites of polymethoxyflavones with high sensitivity by electrochemical detection in high-performance liquid chromatography. J Agric Food Chem. 63:509–516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang F, Li T, Zhang XQ, Gong Y, Su H, Fan J, Wang L, Hu QD and Tan RZ: Screening of active components in Astragalus mongholicus Bunge and Panax notoginseng formula for anti-fibrosis in CKD: Nobiletin inhibits Lgals1/PI3K/AKT signaling to improve renal fibrosis. Ren Fail. 46:23750332024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu X, Song M, Qiu P, Li F, Wang M, Zheng J, Wang Q, Xu F and Xiao H: A metabolite of nobiletin, 4′-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis. Food Funct. 9:87–95. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qiu P, Dong P, Guan H, Li S, Ho CT, Pan MH, McClements DJ and Xiao H: Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells. Mol Nutr Food Res. 54 (Suppl 2):S244–S252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goh JXH, Tan LT, Goh JK, Chan KG, Pusparajah P, Lee LH and Goh BH: Nobiletin and derivatives: Functional compounds from citrus fruit peel for colon cancer chemoprevention. Cancers (Basel). 11:8672019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moon JY, Manh Hung LV, Unno T and Cho SK: Nobiletin enhances chemosensitivity to adriamycin through modulation of the Akt/GSK3β/β-catenin/MYCN/MRP1 signaling pathway in A549 human non-small-cell lung cancer cells. Nutrients. 10:18292018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang H, Chen H, Jin C, Mo J and Wang H: Nobiletin flavone inhibits the growth and metastasis of human pancreatic cancer cells via induction of autophagy, G0/G1 cell cycle arrest and inhibition of NF-kB signalling pathway. J BUON. 25:1070–1075. 2020.PubMed/NCBI
|
|
26
|
Yang J, Yang Y, Wang L, Jin Q and Pan M: Nobiletin selectively inhibits oral cancer cell growth by promoting apoptosis and DNA damage in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol. 130:419–427. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Q, Gu Y, Tan C, Sundararajan B, Li Z, Wang D and Zhou Z: Comparative effects of five polymethoxyflavones purified from Citrus tangerina on inflammation and cancer. Front Nutr. 9:9636622022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miyata Y, Sato T, Imada K, Dobashi A, Yano M and Ito A: A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochem Biophys Res Commun. 366:168–173. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Da C, Liu Y, Zhan Y, Liu K and Wang R: Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway. Oncol Rep. 35:2767–2774. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao XJ, Liu JW, Zhang QG, Zhang JJ, Xu HT and Liu HJ: Nobiletin inhibited hypoxia-induced epithelial-mesenchymal transition of lung cancer cells by inactivating of Notch-1 signa ling and switching on miR-200b. Pharmazie. 70:256–262. 2015.PubMed/NCBI
|
|
31
|
Keshtkar S, Kaviani M, Jabbarpour Z, Geramizadeh B, Motevaseli E, Nikeghbalian S, Shamsaeefar A, Motazedian N, Al-Abdullah IH, Ghahremani MH and Azarpira N: Protective effect of nobiletin on isolated human islets survival and function against hypoxia and oxidative stress-induced apoptosis. Sci Rep. 9:117012019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin Z, Wu D, Huang L, Jiang C, Pan T, Kang X and Pan J: Nobiletin inhibits IL-1β-induced inflammation in chondrocytes via suppression of NF-κB signaling and attenuates osteoarthritis in mice. Front Pharmacol. 10:5702019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Youn K, Lee S and Jun M: Discovery of nobiletin from citrus peel as a potent inhibitor of β-amyloid peptide toxicity. Nutrients. 11:26482019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsuboi T, Lu R, Yonezawa T, Watanabe A, Woo JT, Abe-Dohmae S and Yokoyama S: Molecular mechanism for nobiletin to enhance ABCA1/G1 expression in mouse macrophages. Atherosclerosis. 297:32–39. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang BF, Jiang H, Ch J, Guo X, Li Y, Hu Q and Yang S: Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway. Int Immunopharmacol. 73:98–107. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuk T, Kim Y, Yang J, Sung J, Jeong HS and Lee J: Nobiletin inhibits hepatic lipogenesis via activation of AMP-activated protein kinase. Evid Based Complement Altern Med. 2018:74202652018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li S, Pan MH, Lai CS, Lo CY, Dushenkov S and Ho CT: Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines. Bioorg Med Chem. 15:3381–3389. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xiao H, Yang CS, Li S, Jin H, Ho CT and Patel T: Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel inhibit growth of human lung cancer cells by apoptosis. Mol Nutr Food Res. 53:398–406. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Asakawa T, Sagara H, Kanakogi M, Hiza A, Tsukaguchi Y, Ogawa T, Nakayama M, Ouchi H, Inai M and Kan T: Practical synthesis of polymethylated flavones: Nobiletin and its desmethyl derivatives. Org Process Res Dev. 23:595–602. 2019. View Article : Google Scholar
|
|
40
|
Song M, Lan Y, Wu X, Han Y, Wang M, Zheng J, Li Z, Li F, Zhou J, Xiao J, et al: The chemopreventive effect of 5-demethylnobiletin, a unique citrus flavonoid, on colitis-driven colorectal carcinogenesis in mice is associated with its colonic metabolites. Food Funct. 11:4940–4952. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song M, Wu X, Charoensinphon N, Wang M, Zheng J, Gao Z, Xu F, Li Z, Li F, Zhou J and Xiao H: Dietary 5-demethylnobiletin inhibits cigarette carcinogen NNK-induced lung tumorigenesis in mice. Food Funct. 8:954–963. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nemoto K, Ikeda A, Yoshida C, Kimura J, Mori J, Fujiwara H, Yokosuka A, Mimaki Y, Ohizumi Y and Degawa M: Characteristics of nobiletin-mediated alteration of gene expression in cultured cell lines. Biochem Biophys Res Commun. 431:530–534. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang X, Zheng K, Li C, Zhao Y, Li H, Liu X, Long Y and Yao J: Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells. Oncol Rep. 37:2847–2856. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Andugulapati SB, Gourishetti K, Tirunavalli SK, Shaikh TB and Sistla R: Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems. Phytomedicine. 78:1532982020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma X, Xie Y, Gong Y, Hu C, Qiu K, Yang Y, Shen H, Zhou X, Long C and Lin X: Silibinin prevents TGFβ-induced EMT of RPE in proliferative vitreoretinopathy by inhibiting Stat3 and Smad3 phosphorylation. Invest Ophthalmol Vis Sci. 64:472023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Peng L, Wen L, Shi QF, Gao F, Huang B, Meng J, Hu CP and Wang CM: Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation. Cell Death Dis. 11:9782020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu F, Zhang S, Yin M, Guo L, Xu M and Wang Y: Nobiletin inhibits hypoxia-induced epithelial-mesenchymal transition in renal cell carcinoma cells. J Cell Biochem. 120:2039–2046. 2019. View Article : Google Scholar : PubMed/NCBI
|
